Greenleaf Trust Catalent, Inc. Transaction History

Greenleaf Trust

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$56.16 - $60.96 $23,362 - $25,359	416 Added 10.73%	4,294 $260,000
Q2 2024 Jul 22, 2024	BUY	$53.58 - $57.02 $207,783 - $221,123	3,878 New	3,878 $218,000
Q1 2023 May 11, 2023	BUY	$45.44 - $74.26 $253,146 - $413,702	5,571 New	5,571 $366,000
Q2 2022 Aug 12, 2022	BUY	$87.2 - $114.05 $1,656 - $2,166	19 Added 0.58%	3,270 $351,000
Q1 2022 Apr 27, 2022	SELL	$94.19 - $124.49 $32,024 - $42,326	-340 Reduced 9.47%	3,251 $361,000
Q4 2021 Feb 11, 2022	BUY	$119.57 - $139.07 $7,174 - $8,344	60 Added 1.7%	3,591 $460,000
Q3 2021 Nov 12, 2021	BUY	$109.17 - $142.35 $49,999 - $65,196	458 Added 14.9%	3,531 $470,000
Q2 2021 Aug 10, 2021	BUY	$100.34 - $115.69 $4,414 - $5,090	44 Added 1.45%	3,073 $332,000
Q1 2021 Apr 30, 2021	BUY	$101.51 - $125.27 $63,545 - $78,419	626 Added 26.05%	3,029 $319,000
Q4 2020 Feb 08, 2021	BUY	$85.88 - $105.36 $206,369 - $253,180	2,403 New	2,403 $250,000

463

148M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Greenleaf Trust, based on Form 13F filings with the SEC.

Stay updated on Greenleaf Trust with notifications on news.